BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14

• Press Releases

  Revance and Teoxane Announce the FDA Approval of RHA® Dynamic Volume for Midface Contour Deficiencies

  January 14, 2026

   · 

  10 min read
• Press Releases

  Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

  January 14, 2026

   · 

  5 min read
• Press Releases

  The Mark Foundation for Cancer Research Announces 2026 Emerging Leader Awards, Committing $3.75 Million to Next-Generation Oncology Breakthroughs

  January 14, 2026

   · 

  4 min read
• Press Releases

  Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife

  January 14, 2026

   · 

  4 min read
• Press Releases

  Enspire DBS Therapy Announces $10.3 Million Series B1 Financing to Advance Pivotal Development of DBS-Enabled Stroke Rehabilitation

  January 14, 2026

   · 

  3 min read
• Press Releases

  Thryv Therapeutics Launches Pivotal Wave II Phase 2/3 Study in Long QT Syndrome Type 2

  January 14, 2026

   · 

  4 min read
• Press Releases

  ClinNEXUS Appoints Jovan Hollins to Chief Operating Officer

  January 14, 2026

   · 

  2 min read
• Press Releases

  Biokin to Present at J.P. Morgan’s 44th Annual Healthcare Conference

  January 14, 2026

   · 

  1 min read
• Press Releases

  ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer

  January 14, 2026

   · 

  9 min read
• Press Releases

  U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia

  January 14, 2026

   · 

  8 min read